ICH E6(R3) is not just a refresh of familiar GCP language. It is a clearer statement of what modern sponsor oversight should look like in an increasingly outsourced, technology-enabled and risk-based clinical trial environment.
The final ICH E6(R3) guideline was adopted on 6 January 2025. MHRA’s UK guidance states that compliance with the ICH E6 GCP principles became a legal requirement in the United Kingdom on 28 April 2026, while the Annexes must still be given due regard as relevant guidance. For trials intended to support marketing authorisations, MHRA says compliance with the Annexes in addition to the principles would be expected.
For sponsors, five messages stand out.
First, oversight is explicitly risk-proportionate. The sponsor section opens by stating that sponsor responsibility entails implementing risk-proportionate approaches across the clinical trial lifecycle. Oversight is no longer framed as a generic control exercise; it is expected to be tailored to the complexity of the trial and the importance of the activities being overseen.
Second, quality by design is now central. E6(R3) expects sponsors to build quality into trial design, identify factors critical to quality, and manage risks that could affect participant safety or the reliability of results. In practice, that means sponsor oversight should start at protocol and operating model design stage, not only once Service Providers are live.
Third, service provider oversight is more explicit and more operational. The guideline states that sponsors remain ultimately responsible, must assess provider suitability, should have access to relevant information such as SOPs and performance metrics, and should oversee important activities even where they are further subcontracted.
Fourth, systems oversight matters more than ever. E6(R3) emphasises that trial systems and processes should be fit for purpose, and that computerised systems used in clinical trials should be validated accordingly. It also expects technical issues to be documented, reviewed and resolved according to criticality. That is highly relevant for modern outsourced models involving eTMF, EDC, IRT, digital endpoints and specialist platforms.
Fifth, oversight must be evidenced. E6(R3) expects essential records to document service provider qualification and sponsor oversight of important delegated activities. This is a key shift in emphasis: not just doing oversight, but being able to reconstruct and demonstrate it.
Taken together, E6(R3) moves sponsor oversight away from a box-checking model and toward a more strategic, risk-based and evidence-driven approach. That is the real opportunity for sponsors: not simply to comply with new wording, but to build oversight models that are stronger, smarter and easier to defend.
MSAQS helps sponsors translate ICH GCP E6(R3) into practical oversight frameworks, Service Providers governance processes and audit-ready QA systems.
